Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Immunology · Autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation

Symptoms and How APLAID Affects the Body

At a Glance

APLAID is caused by an abnormal change in the PLCG2 gene that can trigger inflammation while weakening antibody protection. Symptoms may include fever and painful rashes, repeated infections, and inflammation in the lungs, gut, joints, or eyes.

Living with APLAID means managing a complex condition where the immune system’s signaling is fundamentally altered. While most people think of the immune system as either working well or being weakened, APLAID causes dysregulation that leads to both inappropriate inflammation and a vulnerability to infection [1]. This occurs because of a specific genetic change that disrupts how your body’s defense cells communicate [2].

The Genetic Alteration

The root of APLAID is typically a gain-of-function mutation in the PLCG2 gene [2]. This gene provides instructions for making a protein called PLCγ2, which acts as a signaling relay within immune cells [3].

In APLAID, the mutation alters this signaling pathway, causing it to react abnormally [2][4]. This abnormal signaling can trigger the release of inflammatory chemicals even when there is no infection present, leading to systemic inflammation [2].

A Two-Front Challenge

Because the PLCγ2 protein is involved in multiple immune pathways, its malfunction creates two different sets of problems:

  1. Systemic Autoinflammation: The altered signaling causes the body to trigger inappropriate inflammation, leading to fevers, painful rashes, and organ inflammation [1][5].
  2. Immune Deficiency: The same abnormal signaling can disrupt the development and function of B cells (the cells that make antibodies) [4]. This leads to antibody deficiency, making you more vulnerable to actual bacterial and respiratory infections [4][6].

How APLAID Affects the Body

APLAID can cause symptoms in many different organ systems. These symptoms often appear in “flares” that can vary in severity [1].

  • Skin: This is often an early sign [7]. It typically appears as vesiculopustular rashes—small, blistering, or pus-filled bumps—or red, thickened plaques [1][7]. While these rashes are primarily driven by internal inflammation, they can still become infected by bacteria or fungi. Any new, changing, draining, or highly painful lesions should be evaluated by a doctor.
  • Respiratory System: Due to the antibody deficiency, recurrent infections of the sinuses and chest (like bronchitis) are common [1][6]. Over time, repeated inflammation can also lead to structural changes in the lungs, such as interstitial pneumonitis (inflammation of the tissue around the air sacs) [1][5].
  • Digestive Tract: Some patients develop colitis (inflammation of the colon) or symptoms resembling Inflammatory Bowel Disease (IBD), including chronic diarrhea or abdominal pain [8][1].
  • Joints and Eyes: Chronic inflammation can lead to arthralgia (joint pain) or severe arthritis [9][5]. It can also cause uveitis (serious inflammation inside the eye) or conjunctivitis (inflammation of the surface of the eye) [1][10].

APLAID vs. PLAID: Typical Features

You may hear about a related condition called PLAID. While both involve the PLCG2 gene, their clinical patterns typically differ, though some overlap exists:

Feature Typical in APLAID Typical in PLAID
Cold Sensitivity Usually absent (or not the primary feature) [1] Cold-induced urticaria (hives from cold) [11]
Main Skin Symptom Blisters and pustules [1] Hives [11]
Gene Change Missense mutation (a single letter change) [12] Deletion (a missing piece of DNA) [13]

While the absence of cold-induced hives is a useful clue that points toward APLAID, it is not an absolute rule. Accurate diagnosis requires looking at the specific genetic mutation alongside the clinical symptoms [1][10].

Brief Glossary of Terms

  • PLCγ2: The protein that relays signals inside immune cells.
  • B cells: White blood cells that produce antibodies to fight infections.
  • Interstitial pneumonitis: Inflammation of the lung tissue that can affect breathing.
  • Uveitis: Serious inflammation deep inside the eye (different from surface redness or ‘pink eye’) that requires prompt medical attention to protect vision.

Common questions in this guide

What symptoms can APLAID cause?
APLAID can cause episodes of fever and inflammation along with problems caused by low antibody protection. Symptoms may include blistering or pus-filled rashes, repeated sinus or chest infections, lung inflammation, digestive symptoms, joint pain, and eye inflammation.
Why can APLAID cause both inflammation and infections?
An activating change in the PLCG2 gene can make immune signaling trigger inflammation at the wrong time. It can also interfere with B cells, which make antibodies, leaving a person more vulnerable to bacterial and respiratory infections.
How is APLAID different from PLAID?
APLAID more often causes blistering or pus-filled rashes and usually does not have cold-triggered hives as its main feature. PLAID more typically causes cold-induced hives and is associated with a different type of PLCG2 change; symptoms can overlap, so diagnosis depends on the clinical pattern and genetic result.
Can an APLAID rash become infected?
Yes. The rash may be driven by inflammation, but damaged skin can also develop a bacterial or fungal infection. New, changing, draining, or very painful lesions should be assessed by a clinician.
Does APLAID affect the lungs and cause repeated infections?
Yes. Antibody deficiency can contribute to repeated sinus infections, bronchitis, and other chest infections. Ongoing inflammation may also cause interstitial pneumonitis, an inflammation of the lung tissue around the air sacs, so ask the treating team whether lung monitoring is appropriate.
What eye or digestive symptoms can occur with APLAID?
APLAID may cause colitis, chronic diarrhea, or abdominal pain, and it can affect the eyes with uveitis or conjunctivitis. Uveitis is inflammation inside the eye and needs prompt medical attention because it can threaten vision.
How can I tell an APLAID flare from an infection?
Symptoms can overlap, so a fever, rash, or worsening respiratory symptom cannot always be classified at home. Inflammatory flares may include fever, painful rashes, or organ inflammation, while antibody deficiency increases the risk of bacterial and respiratory infections; contact your healthcare team for evaluation when symptoms are new, severe, or persistent.

Get notified when new evidence is published on Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Novel PLCG2 Mutation in a Patient With APLAID and Cutis Laxa.

    Neves JF, Doffinger R, Barcena-Morales G, et al.

    Frontiers in immunology 2018; (9()):2863 doi:10.3389/fimmu.2018.02863.

    PMID: 30619256
  2. 2

    Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor.

    Yang Z, Tao P, Han X, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2024; (76(11)):1670-1678 doi:10.1002/art.42948.

    PMID: 38965708
  3. 3

    A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases.

    Novice T, Kariminia A, Del Bel KL, et al.

    Journal of clinical immunology 2020; (40(2)):267-276 doi:10.1007/s10875-019-00731-3.

    PMID: 31853824
  4. 4

    Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations.

    Martín-Nalda A, Fortuny C, Rey L, et al.

    Journal of clinical immunology 2020; (40(7)):987-1000 doi:10.1007/s10875-020-00794-7.

    PMID: 32671674
  5. 5

    Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review.

    Wu N, Zhang B, Wang T, et al.

    Frontiers in immunology 2021; (12()):667430 doi:10.3389/fimmu.2021.667430.

    PMID: 34093563
  6. 6

    Variant in the PLCG2 Gene May Cause a Phenotypic Overlap of APLAID/PLAID: Case Series and Literature Review.

    Welzel T, Oefelein L, Holzer U, et al.

    Journal of clinical medicine 2022; (11(15)) doi:10.3390/jcm11154369.

    PMID: 35955991
  7. 7

    Expanding the clinical features of autoinflammation and phospholipase Cγ2-associated antibody deficiency and immune dysregulation by description of a novel patient.

    Morán-Villaseñor E, Saez-de-Ocariz M, Torrelo A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(12)):2334-2339 doi:10.1111/jdv.15918.

    PMID: 31465591
  8. 8

    Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2.

    Peng Q, Luo D, Yang Y, et al.

    Frontiers in immunology 2023; (14()):1014150 doi:10.3389/fimmu.2023.1014150.

    PMID: 36776842
  9. 9

    A new report of autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation (APLAID) with a homozygous pattern from Iran.

    Khabbazi A, Rahbar Kafshboran H, Nasiri Aghdam M, et al.

    Immunology letters 2020; (221()):27-32 doi:10.1016/j.imlet.2020.01.008.

    PMID: 32014489
  10. 10

    Case Report: de novo in-frame deletion in PLCG2 gene: a case report of B-cell lymphopenia, pulmonary bullae, and cutis laxa.

    Wu X, Zhang J, Shen M

    Frontiers in immunology 2025; (16()):1556372 doi:10.3389/fimmu.2025.1556372.

    PMID: 40170866
  11. 11

    PLAID: a Syndrome of Complex Patterns of Disease and Unique Phenotypes.

    Milner JD

    Journal of clinical immunology 2015; (35(6)):527-30 doi:10.1007/s10875-015-0177-x.

    PMID: 26206677
  12. 12

    Functional characterization of phospholipase C-γ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder.

    Walliser C, Wist M, Hermkes E, et al.

    Oncotarget 2018; (9(76)):34357-34378 doi:10.18632/oncotarget.26173.

    PMID: 30344948
  13. 13

    Cool-temperature-mediated activation of phospholipase C-γ2 in the human hereditary disease PLAID.

    Schade A, Walliser C, Wist M, et al.

    Cellular signalling 2016; (28(9)):1237-1251 doi:10.1016/j.cellsig.2016.05.010.

    PMID: 27196803

This page explains how APLAID can affect the body for informational purposes only and does not replace medical advice. Ask your healthcare team about your symptoms, infection risk, genetic findings, and any urgent eye or breathing concerns.